RecruitingNCT02249923
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
Sponsor
New York Medical College
Enrollment
2,500 participants
Start Date
Oct 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.
Eligibility
Min Age: 1 DayMax Age: 21 Years
Inclusion Criteria3
- The subject's age of onset of pulmonary hypertension must be prior to age 18 years
- The person providing consent must be able to read either Spanish or English.
- The subject (and/or parent/legal guardian) must be able to provide informed consent
Exclusion Criteria2
- Diagnosed with pulmonary hypertension after age 18
- Refusal to sign informed consent
Locations(14)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02249923
Related Trials
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
NCT065543011 location
Spironolactone for Pulmonary Arterial Hypertension
NCT017126201 location
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
NCT0721802963 locations
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
NCT0558771235 locations
Pulmonary Hypertension in Left Heart Disease
NCT059356051 location